Innovating Works

MURSLA LIMITED

EVEREST: Extracellular Vesicle Research Exchanges for Advanced Biomarkers and Therapeutics The EVEREST project is a pioneering consortium in Extracellular Vesicle (EVs) research, bringing together 22 institutions from 11 countries,...
2024-08-01 - 2028-12-31 | Financiado
CRYSTAL3: Commercial Research Opportunity for Cysteinyl Leukotriene Signalling in Ocular CNS Dysfunction... MURSLA LIMITED participó en un H2020: H2020-MSCA-RISE-2020 Cysteinyl leukotrienes (CysLTs) are potent lipid mediators of inflammation. CysLT1 and 2 receptors are widely expressed e.g. lungs, colorect...
2020-10-02 - 2024-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.